951 results on '"Di Forti, Marta"'
Search Results
2. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking
3. The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis
4. Structural brain abnormalities and aggressive behaviour in schizophrenia: Mega-analysis of data from 2095 patients and 2861 healthy controls via the ENIGMA consortium
5. Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses.
6. Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations
7. Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users
8. Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London
9. Salivary cortisol measures across the clinical stages of psychosis: An individual participant data (IPD) meta-analysis
10. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
11. Genetic variants associated with longitudinal changes in brain structure across the lifespan
12. Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia
13. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study
14. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
15. Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium
16. The effect of the COVID-19 pandemic on the treated incidence of psychotic disorders in South London
17. Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UK
18. Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study
19. Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles
20. Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium
21. First-episode Psychosis and Migration in Italy : Results from a Study in the Italian Mental Health Services (Pep-Ita Study)
22. COVID-19 and UK family carers: policy implications
23. The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
24. Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samples
25. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
26. Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).
27. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study
28. 455. AI-Derived Neuroanatomical Subtypes of Schizophrenia and Their Expression During Disease Onset and in Unaffected Siblings
29. The role of social deprivation and cannabis use in explaining variation in the incidence of psychotic disorders: findings from the EU-GEI study
30. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
31. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study
32. Investigating the effects of genetic risk of schizophrenia on behavioural traits
33. IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use
34. Differential gene expression analysis in blood of first episode psychosis patients
35. Tobacco smoking and nicotine dependence in first episode and established psychosis
36. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
37. Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis
38. Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse
39. Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study
40. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking
41. Cannabis Use is Associated with Increased Risk of Violence; a Systematic Review and Meta-Analysis
42. Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression
43. Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study
44. Complement system biomarkers in first episode psychosis
45. Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
46. Systematic review and meta-analysis on the effects of chronic peri-adolescent cannabinoid exposure on schizophrenia-like behaviour in rodents
47. Predicting First-Episode Psychosis Associated with Cannabis Use with Artificial Neural Networks and Deep Learning
48. Can Artificial Neural Networks Predict Psychiatric Conditions Associated with Cannabis Use?
49. Cortical thickness correlates of minor neurological signs in patients with first episode psychosis
50. Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.